[INVNT GROUP]™ Bets Big on Live; Enhances Live Brand Storytelling Capabilities with Newly Formed ITP LIVE, in the Strategic Acquisitions of InSync Production Services, Thunder Audio and Morpheus Lights.

New York, Dec. 29, 2021 (GLOBE NEWSWIRE) — [INVNT GROUP] THE GLOBAL BRANDSTORY PROJECT announces the strategic acquisitions of four historied live event production companies: ITP LIVE, InSync Production Services, Thunder Audio, and Morpheus Lights.

Led by President and CEO, Scott Cullather, [INVNT GROUP] represents a growing portfolio of complementary disciplines designed to help forward thinking brands everywhere, impact the audiences that matter anywhere.

"This deal is a key pillar of our integrated vertical growth strategy as [INVNT GROUP] THE GLOBAL BRANDSTORY PROJECT. The dedicated search for these four companies has been in development for over 18 months. We sought leaders in the technical and production aspects of the live events industry, who were delivering premier production services to legacy brands and many of the world's biggest peforming artists. These acquisitions will expand our innovation capabilities, allowing INVNT, our live events business, to offer our customers the ultimate in live events and experiential activations."

Scott Cullather, President and CEO, [INVNT GROUP]

[INVNT GROUP] consists of modern brand strategy firm, Folk Hero; creative–led culture consultancy, Meaning; branded content studio and content marketing agency HEV'; collegiate events and experiences, INVNT Higher Education, the original global live brand storytelling agency, INVNT and now ITP LIVE consisting of: InSync Production Services, Thunder Audio and Morpheus Lights.

For more than twenty–five years, these production companies have supported the design and execution of experiential and live entertainment programs for many of the largest corporations, trade associations, sports franchises, governmental agencies (including the White House), and some of the most successful artists in the world: Bruce Springsteen, Snoop Dog, Lady Gaga, Lionel Richie, Billy Joel, Diana Ross, Metallica, Post Malone, Tyler Perry and more.

The companies will continue to operate under their current names and will service their existing roster of clients, seek new clients, and providing services to synergistic INVNT opportunities and projects.

"Historically, producing live events has often required a great deal of outsourcing on virtually every project. Through these strategic acquisitions we will have end–to–end control over every aspect of our live events – especially quality and cost, continuing to deliver world–class service and at the very best value. The merging of resources and networks also gives us geographical spread across North America. Our anticipation is to continue growing these resources in other territories around the world. This is only the beginning."

Kristina McCoobery, COO [INVNT GROUP] and CEO INVNT

Rooted in experiential marketing, [INVNT GROUP]'s expansion comes as part of a strategic, yet natural evolution. This business partnership creates a unique offering in the market, and enhances the group's abilities to fulfill creative, technological, and strategic designs in dynamic new ways.

"When [INVNT GROUP] approached us about the idea of coming together and amplifying our resources, I was instantly drawn to the group's commitment to impactful storytelling. Their award–winning work aligns with our vision of the newly formed ITP LIVE, that includes Insync Production Services, Thunder Audio and Morpheus Lights,. We're excited by the incredible synergies created through our partnership and welcome a new chapter in designing the best events on the planet."


This transaction was structured by Wolf Karbe, CFO of [INVNT GROUP] and represented by Evergreen Advisors Capital and Center Rock Advisors. Financial terms of the transaction were not disclosed.



[INVNT GROUP] was established in 2020, as an evolution of the founding global live brand storytelling agency INVNT in 2008, with a vision to provide consistent, meaningful, well–articulated BrandStory across all platforms. With offices in New York, Sydney, London, Singapore, San Francisco, Sydney, Stockholm, Detroit, and Washington D.C.; headed by President and CEO, Scott Cullather, [INVNT GROUP], THE GLOBAL BRANDSTORY PROJECT represents a growing portfolio of complementary disciplines designed to help forward–thinking organizations everywhere, impact the audiences that matter, anywhere. The GROUP consists of modern brand strategy firm, Folk Hero; creative–led culture consultancy, Meaning; branded content studio and content marketing agency HEV', INVNT Higher Ed; events for colleges and universities, and the original live brand storytelling agency, INVNT. For more information about [INVNT GROUP], visit: www.invntgroup.com.


Founded in 2008 by Scott Cullather and Kristina McCoobery, INVNT uses the craft of live brand storytelling to create and produce live experiences that excite and unite physical and virtual audiences, globally. The company's "challenge everything' positioning statement helps clients including General Motors, PepsiCo, Merck, Microsoft, Pfizer, and Samsung share their stories with every audience that matters. INVNT's offices are strategically located in New York, London, Sydney, Detroit, San Francisco, Washington D.C., Stockholm and Singapore. For more information about INVNT, visit: www.invnt.com.


ITP Live "" Ideas. Technology. People. was Founded by Pat Hand (CEO) and Paul Mullen (COO) who collectively have over 60 years of experience in event design and production management. Pat Hand, former CEO, PRG Mid–Atlantic and Paul Mullen former President and CEO, Greyhound Exposition Services have created, managed, and integrated world class companies and were forerunners of providing end to end, turnkey production solutions. Their strategy spans from concept through execution with a true 360 production approach. Pat and Paul will oversee management for InSync, Thunder Audio and Morpheus Lights, to ensure smooth integration and growth while fully maximizing production synergies with INVNT creating significant cost savings while ensuring best in class production support services. For more information about ITP LIVE, visit: www.itplive.com


An iconic show production company, founded over 25 years ago in Las Vegas, the entertainment capital of the world, powering the Indy 500, Super Bowl and supporting clients that include L'Oreal, Dell Computers, Nissan, Verizon and Wells Fargo. Built around the broadcast video landscape, a creative leader leveraging LED technology. For more information about Insync Production Services, visit: www.insyncproductionservices.com.


Thunder Audio, a family owned business for over 42 years, has amplified some of the largest musical artists in the world including: Billy Joel, Post Malone, Elton John, Lionel Ritchie, Metallica, Diana Ross, and Earth Wind and Fire. Thunder Audio design and produce dynamic audio services for live experiences of all varieties and scales. Thunder Audio has always been a part of supporting touring, music festivals, corporate events, broadcast, sporting and governmental events. Providing the finest technology with premier manufacturers in the industry. For more information about Thunder Audio, visit: www.thunderaudioinc.com.


Morpheus Lights has staked a global claim in the art and science of performance illumination in live events. For over 25 years, the company has counted on top–tier technology partners like AYRTON, Martin/Harmon, and Clay Paky to support lighting design and execution on tours and performances for Bruce Springsteen, Ringo Starr, and Lady Gaga. The company uses an eco–conscious approach to all projects, constantly researching for the most environmentally friendly products. For more information about Morpheus Lights, visit: www.morpheuslights.com.


GLOBENEWSWIRE (Distribution ID 8418726)


Dubai, United Arab Emirates, Dec. 28, 2021 (GLOBE NEWSWIRE) — Jetex has received three prestigious recognitions at the World Travel Awards Grand Final:

" World's Leading Private Jet Experience;

" World's Leading FBO Brand; and

" World's Leading Private Jet Terminal for Jetex Paris.

Jetex, an award–winning global leader in executive aviation, triumphed at the 28th annual World Travel Awards. Established in 1993, World Travel Awards acknowledge, reward and celebrate excellence across all sectors of the tourism industry. Today, they are recognized globally as the ultimate hallmark of quality, with winners setting the benchmark to which all others aspire. The voting process is online and engages qualified executives working within travel and tourism and the consumer travel buyer.

Jetex private terminals were voted the world's number one, which isn't the first time they won the top accolade since the first Jetex FBO opened in 2009. Paris Le Bourget is the busiest private jet airport in Europe and Jetex Paris has set a gold standard for the highest levels of comfort and efficiency both for passengers and crews. In August, it enjoyed global media limelight when hundreds of football fans cheered the arrival of Lionel Messi at Jetex Paris to join Paris Saint–Germain. Today, it has been voted the World's Leading Private Jet Terminal.

In 2021, Jetex has further improved the entire travel journey to let travelers enjoy a safer and more seamless experience across all 34 international locations. It all contributed to Jetex being recognized for having implemented the World's Leading Private Jet Experience, from departure to arrival. From the superior comfort of luxurious lounges and exceptional hospitality to the highest levels of aircraft handing expertise and on–time performance, Jetex FBOs around the globe continue leading the industry.

"At Jetex, we strive to enhance our products and guest experience to ensure we are delivering the industry's highest standards and leading the way when it comes to innovation. We are honored that these awards have been voted for by travel and tourism professionals and consumers worldwide, and on behalf of the entire Jetex family, we extend our sincerest thanks to our partners and passengers worldwide," said Adel Mardini, Founder and CEO of Jetex.

Graham Cooke, Founder, World Travel Awards, commented: "Jetex represents the very best of the private aviation universe and I congratulate them on these achievements. It plays a leading role in spearheading the executive aviation sector, facilitating seamless cross–border travel during the most trying times."

Best known for the dramatic transformation of the FBO model, Jetex works closely with leading designers to create bright and airy terminals with luxury amenities ranging from entertainment lounges to lush outdoor gardens and state–of–the–art flight support centers. The company witnessed a substantial increase in private jet movements this year across its entire network and continued to benefit from the momentum to reinforce its brand recognition and awareness, which has now been cemented as the World's Leading FBO Brand.

– END –

About Jetex:

An award–winning global leader in executive aviation, Jetex is recognized for delivering flexible, best–in–class trip support solutions to customers worldwide. Jetex provides exceptional private terminals (FBOs), aircraft fueling, ground handling and global trip planning. The company caters to both owners and operators of business jets for corporate, commercial and personal air travel. To find out more about Jetex, visit www.jetex.com and follow us on Instagram, Twitter, Facebook, and LinkedIn.


GLOBENEWSWIRE (Distribution ID 8417856)


Dubai, United Arab Emirates, Dec. 27, 2021 (GLOBE NEWSWIRE) — For the wealthiest of the wealthy, only the most extravagant and expensive gifts are acceptable during the holiday giving season. This inspired Jetex to design the ultimate "Christmas in the Sky' private jet experience, priced USD 27,000 for up to 10 passengers.

Jetex, an award–winning global leader in executive aviation, invites the lucky few to celebrate style, taste and disposable income with one brilliant idea: a glamorous Christmas onboard a private jet soaring high in the festive skies.

The magical journey will commence with the passengers picked–up by a chauffeur limousine from their residence or hotel and driven in style to Dubai's iconic Jetex VIP Terminal. Upon arrival, they will be welcomed by not one, but 28 spectacular Christmas trees lined up in front of the terminal dressed in more than 15,000 lights as well as Jetex ambassadors who will take care of seamless departure formalities.

This season, the flagship Jetex terminal is a festive wonderland in its own right: from exquisite decorations and live musicians to carefully selected Dom Prignon vintages paired with caviar and gourmet refreshments to delight the senses. Kids will be welcomed by Santa Klaus who will look after them and let them discover the magnificently decorated Christmas trees and Insta–worthy entertainment facilities of the world's most luxurious private jet terminal. As soon as the passengers are in the mood to board, they will be driven to their private aircraft in timeless elegance in one of the Jetex Rolls–Royces.

The special flight will take two hours and the crew will select the most optimal altitude and cruising speed to ensure passengers enjoy sensational window views, including Dubai's world–famous skyline, iconic landmarks, Arabian Gulf and the rolling dunes of the desert.

To take experience personalization further, a Jetex in–flight culinary expert will contact passengers in advance to discuss their dining preferences and design a bespoke menu which will complement many delectable festive treats offered onboard.

Once back on the ground, passengers will be invited to enjoy the rest of the evening in one of the lounges with elegant service and amenities at their leisure, as well as receive signature Jetex Christmas presents.

Adel Mardini, Founder & CEO of Jetex, commented: "Once again, Jetex redefines private jet travel experience as we celebrate the season of togetherness. "Christmas in the Sky' is the epitome of luxury and festive celebrations above the clouds. Dubai is a city of superlatives and this extraordinary package is taking it to new heights. It is a perfect gift, an excellent way to discover the world of private aviation, and to create a treasured memory to cherish for years to come."

By inviting passengers to share a delightful holiday–themed pursuit among friends and family, Jetex provides a safe, relaxed, and joyful haven of kinship and good cheer.

"Christmas in the Sky" private jet package is priced from USD 27,000 (AED 100,000) for up to 10 passengers and will be available between 24 December 2021 and 7 January 2022.

For reservations, please contact Jetex Premier Experience at experience@jetex.com.

– END –

About Jetex:

An award–winning global leader in executive aviation, Jetex is recognized for delivering flexible, best–in–class trip support solutions to customers worldwide. Jetex provides exceptional private terminals (FBOs), aircraft fueling, ground handling and global trip planning. The company caters to both owners and operators of business jets for corporate, commercial and personal air travel. To find out more about Jetex, visit www.jetex.com and follow us on Instagram, Twitter, Facebook, and LinkedIn.


GLOBENEWSWIRE (Distribution ID 8417866)

FDA Authorizes Marketing of 22nd Century Group’s VLN® as a Modified Risk Tobacco Product

  • VLN Is World's First and Only Combustible Cigarette to Receive FDA MRTP Designation
  • FDA Adds Evidence–Based, Headline Claim "Helps You Smoke Less" to Company's Requested Claims
  • VLN 95% Reduced Nicotine Content Cigarettes to Launch in the U.S. Within 90 Days
  • VLN to Launch Outside the U.S. in First Quarter 2022

BUFFALO, N.Y., Dec. 23, 2021 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, announced today that the U.S. Food and Drug Administration (FDA) has authorized the marketing of the Company's VLN King and VLN Menthol King reduced nicotine content cigarettes as modified risk tobacco products (MRTPs). In doing so, the Agency found that VLN "" which smokes, tastes, and smells like a conventional cigarette but contains 95% less nicotine than conventional, highly addictive cigarettes "" "help reduce exposure to, and consumption of, nicotine for smokers who use them."

"Today's decision to authorize VLN 's MRTP application places the FDA and 22nd Century together at the vanguard of transforming the tobacco industry. With 60% of adult smokers in our U.S. market research telling us they are likely to try VLN , this is a complete game–changer for 22nd Century, the tobacco industry, public health, and adult smokers looking to change their relationship with nicotine "" the addictive chemical found in all tobacco products. This is the first, and most likely will be the only, combustible cigarette to ever carry the FDA's MRTP designation. The FDA's decision to require the additional headline claim "Helps You Smoke Less' alongside our requested headline claim of '95% Less Nicotine' gives adult smokers a crystal–clear reason to replace their conventional and highly addictive cigarettes with VLN ," said James A. Mish, chief executive officer at 22nd Century Group.

"Our mission is to find ways to stop tobacco–related disease and death. We know that three out of four adult smokers want to quit and the data on these products show they can help addicted adult smokers transition away from highly addictive combusted cigarettes," said Mitch Zeller, J.D., director of the FDA's Center for Tobacco Products. "Having options like these products authorized today, which contain less nicotine and are reasonably likely to reduce nicotine dependence, may help adult smokers. If adult smokers were less addicted to combusted cigarettes, they would likely smoke less and may be exposed to fewer harmful chemicals that cause tobacco–related disease and death."

"Having secured this FDA marketing order, we are fully prepared to launch VLN with select retail and marketing partners in our pilot markets in the U.S. within the next 90 days and in the first of several global markets by the end of the first quarter of 2022. We are also in discussions with additional retail trade, marketing, and strategic partners to scale VLN sales in the U.S. and internationally, including through potential licensing of our technology to facilitate the broader industry transition to RNC products. We will provide additional details on strategic partners and the rollout of VLN in the coming months," said Mish.

The FDA authorized the marketing of VLN with the following MRTP claims:

  • "Helps you smoke less."
  • "95% less nicotine."
  • "Helps reduce your nicotine consumption."
  • "…Greatly reduces your nicotine consumption."

The FDA's decision to authorize the Company's MRTP claims and to require the additional claim of "Helps You Smoke Less" on every VLN pack and in every VLN advertisement where any of the other authorized claims are also used was based on an extensive body of science consisting of dozens of independent scientific and clinical studies using 22nd Century's reduced nicotine content (RNC) tobacco cigarettes. These studies, which were funded largely by the FDA, the National Institutes of Health (NIH), and other U.S. federal government agencies, as well as studies funded by 22nd Century, show that smokers who use RNC cigarettes "" even those with no intention of quitting at the beginning of the studies "" reduce their nicotine exposure and dependence, smoke fewer cigarettes per day, increase their number of smoke–free days, and double their quit attempts "" all with minimal or no evidence of nicotine withdrawal symptoms or compensatory smoking.

In its announcement of its decision today, FDA explained, "The data also showed it is reasonably likely that using these products reduces nicotine dependence, which is anticipated to lead to long–term reductions in exposure to the smoking–related toxicants associated with morbidity and mortality by reducing smoking. Published studies have shown that significantly reducing the number of cigarettes smoked per day is associated with lower risk of lung cancer and death, with greater reductions in cigarettes per day resulting in less risk. Additionally, as required for authorization, the FDA found that the applications supported consumer understanding of the claims that VLN cigarettes contain much lower levels of nicotine than other cigarettes."

VLN is also the first and only combustible cigarette to come to market that complies with the FDA's proposed nicotine cap for conventional cigarettes in its Comprehensive Plan for Tobacco and Nicotine Regulation as well as New Zealand's recently proposed reduced nicotine content mandate.

"We believe today's announcement by the FDA is a clear indication that the FDA is moving forward with its Plan to address the incredible harms caused by smoking. This plan includes the authorization of less toxic tobacco products such as e–cigarettes and other non–combustible products along with a nicotine cap of 0.5 mg of nicotine per gram of tobacco in combustible tobacco products. This level of nicotine content, which the FDA has described as being 'minimally or non–addictive,' has already been achieved by 22nd Century in its VLN products," said Mish.

The FDA reiterated in its announcement today that it is "committed to moving forward with the rulemaking process to ban menthol as a characterizing flavor in cigarettes and all characterizing flavors in cigars and remains on track to issue proposed rules in the spring of 2022" and that both VLN King and VLN Menthol King cigarettes "could help addicted cigarette smokers reduce their nicotine consumption and the number of cigarettes they smoke per day."

"As the FDA also looks to ban menthol in highly addictive cigarettes, we fully expect the FDA will allow our VLN Menthol cigarettes, which offer little appeal for youth and former smokers because of their reduced nicotine content, to be allowed by the FDA to remain on the market to provide an off–ramp for adult smokers of menthol cigarettes," added Mish.

The FDA's decision further builds on research projecting that an industry product standard to lower nicotine content in cigarettes to minimally or non–addictive levels would significantly change the trajectory of cigarette addiction, which is the leading cause of preventable disease and death in the U.S. Approximately five million adult smokers would quit within just one year of implementation, more than 33 million people would avoid becoming regular smokers, and more than eight million premature deaths from tobacco could be avoided. With almost half a million Americans dying from smoking and more than $300 billion spent per year on smoking–related diseases, there is a clear and urgent need for substantial change in the tobacco industry.

22nd Century is ready to supply the market with RNC tobacco and finished products such as VLN to enable both 22nd Century and other manufacturers to comply with the proposed nicotine caps in the U.S., New Zealand and other countries as they embrace this innovative and highly effective approach to tobacco harm reduction first proposed by the WHO in 2015. 22nd Century's plant–based technology and products are superior to costly extraction and similar de–nicotinization technologies because those technologies typically use chemicals that strip out not just nicotine but also flavor and aroma compounds, resulting in a product that has been found unacceptable to smokers because it delivers no smoking satisfaction. In contrast, 22nd Century's reduced nicotine tobacco naturally grows with very low levels of nicotine resulting in products that smoke, taste and smell like conventional cigarettes but contain 95% less nicotine than conventional, highly addictive cigarettes. This is critical to creating an acceptable solution and "off–ramp" for current smokers looking to change their relationship with nicotine.

22nd Century remains committed to licensing its technology and products to every manufacturer to enable industry wide compliance with the proposed nicotine caps.

About 22nd Century Group, Inc.
22nd Century Group, Inc. (Nasdaq: XXII) is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. With dozens of patents allowing it to control nicotine biosynthesis in the tobacco plant, the Company has developed proprietary reduced nicotine content (RNC) tobacco plants and cigarettes, which have become the cornerstone of the FDA's Comprehensive Plan to address the widespread death and disease caused by smoking. In tobacco, hemp/cannabis, and hop plants, 22nd Century uses modern plant breeding technologies, including genetic engineering, gene–editing, and molecular breeding to deliver solutions for the life science and consumer products industries by creating new, proprietary plants with optimized alkaloid and flavonoid profiles as well as improved yields and valuable agronomic traits.

Learn more at xxiicentury.com, on Twitter @_xxiicentury, and on LinkedIn.

Learn more about VLN at tryvln.com.

Cautionary Note Regarding Forward–Looking Statements
Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward–looking statements. Forward–looking statements typically contain terms such as "anticipate," "believe," "consider," "continue," "could," "estimate," "expect," "explore," "foresee," "goal," "guidance," "intend," "likely," "may," "plan," "potential," "predict," "preliminary," "probable," "project," "promising," "seek," "should," "will," "would," and similar expressions. Actual results might differ materially from those explicit or implicit in forward–looking statements. Important factors that could cause actual results to differ materially are set forth in "Risk Factors" in the Company's Annual Report on Form 10–K filed on March 11, 2021. All information provided in this release is as of the date hereof, and the Company assumes no obligation to and does not intend to update these forward–looking statements, except as required by law.

Investor Relations & Media Contact:
Mei Kuo
Director, Communications & Investor Relations
22nd Century Group, Inc.
(716) 300–1221

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f2454099–23c6–4b74–a46b–28fbb97124d5

GLOBENEWSWIRE (Distribution ID 8417321)

FXCM November Single Share & Stock Baskets Report

JOHANNESBURG, South Africa, Dec. 23, 2021 (GLOBE NEWSWIRE) — FXCM Group, LLC ("FXCM Group' or "FXCM'), the leading international provider of online foreign exchange trading, CFD trading, cryptocurrencies and related services, is today releasing its data of most popular instruments for the month of November in its Single Share CFD and proprietary Stock Basket product lines.

FXCM offers fractional single share trading with no commission fees* on leading companies from the US, UK, France, Germany, Hong Kong and Australia. FXCM's stock basket products combine the shares of multiple companies from one sector into a single tradeable instrument. The company currently boasts a portfolio of 16 stock baskets. The list of companies and weightings is available on FXCM's stock basket website (https://www.fxcm.com/za/stock–baskets/)

There was little change to the FXCM's top ten during November, with only PayPal making way for Chinese ADR JD.com. Tesla maintained top spot, while Facebook's delayed ticker change did not detract from trader interest as it pushed its way into second spot, recording its highest volume of the last 12 months.

In a month that saw the launch of two new FXCM Stock Baskets, Uranium and Crypto stocks, it was the two Ecommerce baskets that saw the biggest boost ahead of the festive season. China Ecommerce and US Ecommerce jumped to second and fourth place respectively, trailing behind FAANG which has maintained top spot since June. However, with many Chinese companies threatening delistings from the US, it will be interesting to see what the future entails for the components of the both the China Ecommerce basket and the 5th rank China Technology basket as we approach the new year.

Volume Rank Monthly Rank Change Company Symbol
1 Tesla Inc TSLA.us
2 '2 Facebook (Meta Platforms Inc) FB.us
3 "1 Apple Inc AAPL.us
4 '3 Boeing Company BA.us
5 '1 Tencent Holdings Ltd TENC.hk
6 "3 Amazon.com Inc AMZN.us
7 '3 Alphabet Inc GOOG.us
8 "3 Alibaba Group Holding Ltd ADR BABA.us
9 NVIDIA Corporation NVDA.us
10 New to top 10 JD.com JD.us

Volume Rank Monthly Rank Change Sector Symbol
1 Big US Tech FAANG
2 '2 China Ecommerce CHN.ECOMM
3 '4 Airlines AIRLINES
4 '6 US E–Commerce US.ECOMM
5 "–2 China Tech CHN.TECH
6 '5 ESports & Gaming ESPORTS
7 '2 Big China Tech (HKD Basket) ATMX
8 "–2 Cannabis CANNABIS
9 "7 Biotechnology BIOTECH
10 "5 US Banks US.BANKS

Past Performance and popularity is not an indicator of future results.
Rank is derived from FXCM Client Volume

*FXCM can be compensated in several ways, which includes but are not limited to adding a mark–up to the spreads it receives from its liquidity providers, adding a mark–up to rollover, etc. Commission–based pricing is applicable to Active Trader account types.

About FXCM:

FXCM is a leading provider of online foreign exchange (FX) trading, CFD trading, and related services. Founded in 1999, the company's mission is to provide global traders with access to the world's largest and most liquid market by offering innovative trading tools, hiring excellent trading educators, meeting strict financial standards and striving for the best online trading experience in the market. Clients have the advantage of mobile trading, one–click order execution and trading from real–time charts. In addition, FXCM offers educational courses on FX trading and provides trading tools, proprietary data and premium resources. FXCM Pro provides retail brokers, small hedge funds and emerging market banks access to wholesale execution and liquidity, while providing high and medium frequency funds access to prime brokerage services via FXCM Prime. FXCM is a Leucadia Company.

Forex Capital Markets Limited: FCA registration number 217689 (www.fxcm.com/uk)

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.

67% of retail investor accounts lose money when trading CFDs with this provider.

You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

FXCM EU LTD: CySEC license number 392/20 (www.fxcm.com/eu)

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.

Between 74–89% of retail investor accounts lose money when trading CFDs.

You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

FXCM Australia Pty. Limited: AFSL 309763. Losses can exceed your deposited funds. The products may not be suitable for all investors. Please ensure that you fully understand the risks involved. If you decide to trade products offered by FXCM AU, you must read and understand the Financial Services Guide, Product Disclosure Statement, Target Market Determination and Terms of Business on www.fxcm.com/au.

FXCM South Africa (PTY) Ltd: FSP No 46534 (www.fxcm.com/za). Our service includes products that are traded on margin and carry a risk of losses in excess of your deposited funds. The products may not be suitable for all investors. Please ensure that you fully understand the risks involved.

FXCM Markets Limited: Losses can exceed deposited funds. (www.fxcm.com/markets).

Media contact:
Chatsworth Communications
+44 (0) 20 7440 9780

GLOBENEWSWIRE (Distribution ID 8416549)

Hitachi Energy wins major contract for the first-of-its-kind sub-sea power transmission network in the MENA region advancing a sustainable energy future for Abu Dhabi

Zurich, Switzerland, Dec. 22, 2021 (GLOBE NEWSWIRE) — Hitachi Energy today announced it has won a major order from Samsung C&T Corporation, one of the world's largest engineering and construction companies, to connect ADNOC's offshore operations to the onshore power grid in the United Arab Emirates owned and operated by Abu Dhabi National Energy Company PJSC (TAQA).

Hitachi Energy's HVDC Light technology and MACHTM digital control platform1 will enable the transfer of cleaner and more efficient power from the mainland to power ADNOC's offshore production operations, enabling a carbon footprint reduction of ADNOC's offshore operations by more than thirty percent.

This innovative solution reinforces Hitachi Energy's commitment to helping customers and countries to transition towards a carbon–neutral future and help enable the "2050 Net–Zero Initiative' of the UAE.

With a capacity of 3,200 megawatts (MW), the two HVDC links will be by far the most powerful power–from–shore solution in the Middle East and North America (MENA) region to date. It is also the first HVDC power–from–shore solution outside Norwegian waters. This innovative solution reflects how Hitachi Energy continues to pioneer technology to address the growing interest from national and independent oil and gas companies to power their offshore production facilities with carbon–free energy from onshore power grids.

"We are proud to be enabling Abu Dhabi and ADNOC to make significant progress on their pathway toward achieving the United Arab Emirates' ambition to be carbon–neutral by 2050," said Claudio Facchin, CEO of Hitachi Energy. He continued, "At Hitachi Energy we are championing the urgency of the clean energy transition, and this major order is further evidence that we are a "go to' partner for developing and deploying technologies and solutions that are advancing the world's energy system to be more sustainable, flexible and secure."

Mr. SH Kim, Procurement Manager at Samsung C&T Corporation, commented, "In Hitachi Energy, we have selected a trusted partner who brings deep global competence and a strong mindset of collaboration and innovation." SH Kim continued, "Together, we will serve ADNOC with pioneering technologies that are proven to deliver for such a large HVDC project."

The entire power–from–shore project will comprise two HVDC power links, which will connect two clusters of offshore oil and gas production facilities to the mainland power grid, a distance of up to 140 kilometers for each cluster.

Hitachi Energy is supplying four converter stations, which convert AC power to DC for transmission in the subsea cables, then reconvert it to AC from DC for use in the offshore power systems. The HVDC technology will be supplied from Hitachi Energy's global competence centers. Also included in the order are system studies, design and engineering, supply, installation supervision and commissioning. Hitachi Energy will support the customers with a long–term life–cycle service agreement leveraging digital technologies to ensure system availability and reliability over the HVDC links' long operating life.

HVDC Light is a voltage source converter technology that was pioneered by Hitachi Energy. It is the preferred technology for many grid applications, including interconnecting national power grids, integrating offshore wind parks with mainland transmission systems, feeding more power into congested city centers, interconnecting asynchronous networks that operate at different frequencies, and power from shore.

HVDC Light's defining features include uniquely compact converter stations (which is extremely important in space–critical applications like offshore wind, offshore production facilities and city–center infeeds), exceptionally low electrical losses, and black–start capability to restore power after a grid outage.

Hitachi Energy pioneered commercial HVDC technology almost 70 years ago and has delivered more than half of the world's HVDC Classic projects and more than 70 percent of the world's voltage source conversion HVDC projects.


  1. Modular Advanced Control for HVDC (MACH)
  2. The estimated reduction in carbon footprint is based on Hitachi Energy's own calculations.

About Hitachi Energy

Hitachi Energy is a global technology leader that is advancing a sustainable energy future for all. We serve customers in the utility, industry and infrastructure sectors with innovative solutions and services across the value chain. Together with customers and partners, we pioneer technologies and enable the digital transformation required to accelerate the energy transition towards a carbon–neutral future. We are advancing the world's energy system to become more sustainable, flexible and secure whilst balancing social, environmental and economic value. Hitachi Energy has a proven track record and unparalleled installed base in more than 140 countries. Headquartered in Switzerland, we employ around 38,000 people in 90 countries and generate business volumes of approximately $10 billion USD.

# # #


GLOBENEWSWIRE (Distribution ID 8416518)

HPTN Studies Inform FDA’s Approval of ViiV Healthcare’s Long-Acting Cabotegravir Injections for HIV Prevention

DURHAM, N.C., Dec. 21, 2021 (GLOBE NEWSWIRE) — Data from the HIV Prevention Trials Network (HPTN) studies HPTN 083 and HPTN 084 helped provide important information for yesterday's decision by the U.S. Food and Drug Administration (FDA) to approve ViiV Healthcare's long–acting cabotegravir (CAB–LA) injections for the prevention of HIV. Sponsored and co–funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), these studies showed that CAB–LA injected once every eight weeks was superior to daily oral tenofovir/emtricitabine (TDF/FTC) for HIV prevention among cisgender men and transgender women who have sex with men (HPTN 083) and cisgender women (HPTN 084). Both studies also demonstrated that CAB–LA was well–tolerated, offering a new and important pre–exposure prophylaxis (PrEP) option for individuals at risk for HIV infection. ViiV Healthcare will market CAB–LA for PrEP under the brand name Apretude.

"This is a truly critical milestone for HIV pre–exposure prophylaxis providing a safe and effective alternative to daily pills," said Dr. Myron Cohen, HPTN co–principal investigator, and director of the Institute for Global Health at the University of North Carolina in Chapel Hill. "Until we have a cure or vaccine, more prevention options that meet the needs of individuals at risk for HIV around the world are essential."

HPTN 083 was co–funded by NIAID and ViiV Healthcare. HPTN 084 was co–funded by NIAID, the Bill & Melinda Gates Foundation, and ViiV Healthcare. Study product was provided by ViiV Healthcare and Gilead Sciences, Inc. Three other NIH institutes also collaborated on HPTN 083 and HPTN 084: the National Institute of Mental Health, the National Institute on Drug Abuse, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

HPTN 083 enrolled 4,570 cisgender men and transgender women who have sex with men at research sites in Argentina, Brazil, Peru, South Africa, Thailand, the U.S., and Vietnam. In the study, 52 HIV infections occurred, with 12 new infections in the CAB arm and 39 new infections in the TDF/FTC arm. These findings translate to a 69 percent reduction in incident HIV infections in study participants given CAB–LA compared to TDF/FTC.

HPTN 084 enrolled 3,223 cisgender women at research sites in Botswana, Eswatini, Kenya, Malawi, South Africa, Uganda, and Zimbabwe. There were three new infections in the CAB arm and 36 new infections in the TDF/FTC arm, a 92 percent reduction in incident HIV infections in study participants given CAB–LA compared to TDF/FTC.

"HIV continues to disproportionately impact specific populations who need new HIV prevention options that are not only convenient but also highly effective," said Dr. Wafaa El–Sadr, HPTN co–principal investigator, director of ICAP, and professor of epidemiology and medicine at Columbia University in New York. "CAB–LA is a long–awaited and welcomed addition to the HIV prevention toolkit, offering a potentially convenient option for so many around the world."

About the HPTN

The HIV Prevention Trials Network (HPTN) is a worldwide collaborative clinical trials network that brings together investigators, ethicists, community members, and other partners to develop and test the safety and efficacy of interventions designed to prevent the acquisition and transmission of HIV. The U.S. National Institute of Allergy and Infectious Diseases, the U.S. National Institute of Mental Health, Office of The Director, the U.S. National Institute on Drug Abuse, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, all part of the U.S. National Institutes of Health, co–fund the HPTN. The HPTN has collaborated with more than 85 clinical research sites in 19 countries to evaluate new HIV prevention interventions and strategies in populations with a disproportionate HIV burden. The HPTN research agenda "" more than 50 trials ongoing or completed with over 161,000 participants enrolled and evaluated "" is focused primarily on discovering new HIV prevention tools and evaluating integrated strategies, including biomedical interventions combined with behavioral risk reduction interventions and structural interventions. For more information, visit hptn.org.

Media inquiries: Eric Miller, +1.919.384.6465; emiller@fhi360.org

GLOBENEWSWIRE (Distribution ID 8416034)

Blue California-FineCap™ Microencapsulation Platform Serves the Purpose

Rancho Santa Margarita, Calif., Dec. 21, 2021 (GLOBE NEWSWIRE) — Blue California, the producer of natural science–based ingredients, provides FineCap a comprehensive microencapsulation technology platform, equipped with 20 microencapsulation technologies, to deliver active ingredients and satisfy our clients' needs.

Microencapsulation is the process in which tiny particles of solid, liquid, or gas are packaged within a matrix to form a capsule. The capsule is coated with a protective layer to avoid degradation from exposure to environmental factors such as water, oxygen, heat, and light.

"Brands that seek to expand their products' qualities and boost their product portfolios will find many benefits to the FineCap platform," said Dr. Cuie Yan, vice president of encapsulation. "FineCap takes microencapsulation a step further by offering a variety of technologies and targeting customers' specific needs in tackling active ingredients with unique characteristics, such as strong odor, taste or stability problems that challenge formulators."

Microencapsulation systems have been widely used across multiple industries, including the pharmaceutical, food, supplement, personal care, and fragrance industries, for active ingredients like medicines, nicotine, flavors/fragrances, polyunsaturated fatty acids, probiotics, natural pigments, vitamins, antioxidants, etc. Space agency NASA also uses encapsulation technologies for spacecraft. The pharmaceutical industry uses microencapsulation often to control the release of active pharma ingredients (API).

Blue California has created the FineCap platform to serve customers' growing demands for better performance of API, functional ingredients, dietary supplements, flavors, fragrances, cosmetics, and personal care products.

For example, FineCap protects API from degradation, unpleasant tastes or aroma, and maintains its efficacy, by controlling its release. FineCap enables flavors to thrive in food and beverages with integrity, intensity, and extended shelf–life.

In fragrances, FineCap guarantees brands to control the precise fragrance release rate, location, and duration. Personal care products benefit from FineCap by protecting the delicate top–notes and cosmetic actives from oxygen, moisture, temperature, and light deterioration. A more comprehensive look into the benefits that FineCap delivers in these product segments can be found here.

"Our comprehensive FineCap platform has been serving and supporting formulators looking to launch market–winning products with better qualities and shelf–life that consumers are seeking," said Dr. Yan. "We're enabling brands to quickly create products from innovative concepts, benchtop development, to pilot and full commercial manufacturing, with improved efficacy, taste, color, texture, and shelf life, along with vegan, organic, Kosher, or Halal certificate."

The FineCap platform investment builds on Blue California's 25–year legacy of producing botanical extracts and now natural flavors and fragrances and focuses on developing sustainable ingredients made through bioconversion or fermentation.


About Blue California
Blue California is an entrepreneurial, science–based solutions provider and manufacturer of clean, natural, and sustainable ingredients used in food, beverage, flavor, fragrance, dietary supplements, personal care, and cosmetic products. For more than 25 years, Blue California has built a strong reputation for creating value in these diverse natural products and nature–inspired industries.


GLOBENEWSWIRE (Distribution ID 8415590)

ISW Holdings Inc. (ISWH) Reports Record Revenue, Forecasts $7M Per Month

NEW YORK, Dec. 20, 2021 (GLOBE NEWSWIRE) — via InvestorWireISW Holdings Inc. (OTC: ISWH) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 50+ trusted brands within the InvestorBrandNetwork ("IBN"), a multifaceted financial news and publishing company for private and public entities.

To view the full publication and forward–looking statements, please visit: https://nnw.fm/YrdIL

Developments are translating to revenue and cash flow, resources that will underscore growth in 2022 and beyond with Pod City and other hosting and mining operations. During Q3, ISW Holdings Inc. (OTC: ISWH) reported revenue from operations of $1.075 million (including deferred revenues), up 2,435% on a year–over–year basis. That didn't include a full three months of 550 new miners acquired from Minerset, 150 of which came as a result of ISWH meeting stock performance milestones. Total assets during Q3 increased 5,263% year to date to $9.56 million, while total liabilities decreased 73%, and total derivative liabilities decreased 98% to under $340,000. …

Looking ahead, revenue at Pod City will be comprised of hosting service fees, which aren't contingent upon cryptocurrency pricing. Once running at full capacity, the company estimates annual revenue in excess of $7 million per month, a tremendous improvement compared to current capacity with the benefit of being recurring under service contracts.

About ISW Holdings

ISW Holdings, based in Nevada, is a diversified portfolio company comprised of essential business lines that serve consumer product demands. The company's expertise lies in strategic brand development, early growth facilitation, as well as brand identity through its proprietary procurement process. Together, with its partners, ISW Holdings seeks to provide a structure that meets large scalability demands, as well as anticipated marketplace needs. The company is able to meet these needs through a variety of strategic innovative processes. ISWH is creating and managing brands across a spectrum of disruptive industries. It maneuvers its proprietary companies through critical stages of market development, which includes conceptualization, go–to–market strategies, engineering, product integration, and distribution efficiency. The company has also partnered with a well–known software development and consulting company, Bengala Technologies LLC, which is developing significant enhancements in the supply chain management space; and the partnership has a vitally needed patent now pending.

For more information about the company, visit www.ISWHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to ISWH are available in the company's newsroom at http://ibn.fm/ISWH.

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever–growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today's market, NNW brings its clients unparalleled visibility, recognition and brand awareness.

To receive SMS text alerts from NetworkNewsWire, text "STOCKS" to 77948 (U.S. Mobile Phones Only).
For more information please visit https://www.NetworkNewsWire.com.

Please see full terms of use and disclaimers on the NetworkNewsWire website, applicable to all content provided by NNW wherever published or re–published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office

NetworkNewsWire is part of the InvestorBrandNetwork

GLOBENEWSWIRE (Distribution ID 8412373)

CMR Surgical expands into the Middle East

CMR Surgical expands into the Middle East

  • Versius being used to perform minimal access surgery (MAS) in several hospitals across the United Arab Emirates (UAE)
  • CMR's new UAE office will be the first office in the Middle East enabling expansion of operations in the region

Cambridge, United Kingdom. 20 December 2021 00:01 (GMT). CMR Surgical (CMR) "" the global surgical robotics business behind the next–generation surgical robotic system, Versius "" has today announced that it has successfully installed Versius into three hospitals in the United Arab Emirates (UAE), as the Company continues to expand globally in line with its mission to bring the benefits of minimal access surgery to more people around the world. To support the region, CMR has invested in the opening of a Middle East hub office in UAE and expects further sales in the region in the short–term.

In partnership with Gulf Drug, Versius has been acquired by hospitals across the UAE, where it is being used in a rapidly increasing number of surgeries in both public and private hospitals including at the Saudi German Hospital, Al Zahra Hospital, and American Hospital Dubai. The UAE, amongst other countries across the Middle East, has made considerable and rapid advances to adopt surgical robotics into clinical practice, and is seeing significant benefits by enabling more patients to receive MAS.

The installation of Versius across the UAE follows the introduction of the system in Europe, India and Australia. Versius has been used to perform a range of surgical specialities including Gynaecology, Colorectal, General and Urology surgeries to date. These include complex cancer cases that would otherwise have had to be performed via open surgical techniques, significantly reducing recovery time for patients and getting them out of hospital sooner.

Per Vegard Nerseth, Chief Executive Officer of CMR Surgical said: "It is wonderful to announce our commercial progress in the Middle East and we are excited to be amongst an ecosystem of innovative companies in Dubai. Our presence in Dubai shows how our business approach on an international scale has evolved, representing expansion into an important region where our mission of increasing access to keyhole surgery really resonates. The rapid pace and adoption of Versius into world class hospitals in Dubai has been outstanding and we look forward to further developments across the Middle East."

Dr Hatem Moussa, Director of General and Oncological Surgery at American Hospital Dubai said: "With Versius, our team has been able to perform highly complex surgeries at high volume with greater dexterity, precision and ease. Having successfully performed fifty minimal access surgeries in forty–five days, the introduction of Versius is allowing us to treat more and more patients using minimal access techniques, which has great benefit for both patients and our surgeons, who would otherwise often experience physical discomfort performing a high number of operations manually. Versius is a great asset to us at American Hospital Dubai and the region overall, and I am delighted we have adopted this innovative new technology."

Dr Reem Osman, Regional Chief Executive Officer at Saudi German Hospital Group said: "Introducing robotic surgery will help our doctors achieve their surgeries with much better results and recovery time, delivering what we always promise "" the best healthcare to our patients. This new state–of–the–art technology that is CMR's Versius Surgical Robotic System is a very important advance to the world of surgery, dynamically digitising healthcare while ensuring a safe and comfortable experience for patients."

The new CMR office, located in the Dubai Free Zone brings together top talent and highly experienced teams to help transform surgery and access to robotics for MAS in an advanced market. The UAE has a well–funded healthcare system looking to adopt new innovations providing an opportunity to bring surgical robotics to an underpenetrated region, for the benefit of hospitals and patients. The purpose–built building includes office space, conference and meeting rooms, and a high–tech robotics lounge to showcase Versius and facilitate training for frequent visiting surgeons. Working with partners, CMR anticipates significant growth in the Middle East region in the coming years.

The announcement follows CMR's commitment to an accelerated commercial expansion following a successful $600 million ( 425 million) Series D funding round, the largest–ever private MedTech raise earlier this year. The funding will support the continued expansion of the company, bringing Versius to more hospitals and patients around the world, as well as the continued development of the Versius digital ecosystem, such as Versius Connect "" a specialised app developed for surgeons using Versius.

"" ENDS ""

Media Contacts:

If you wish to see more, please contact CMR Surgical at:

Press Office, CMR Surgical
T +44 (0)1223 755801
E pressoffice@cmrsurgical.com

Notes to editors:

The Versius Surgical Robotic System

Versius resets expectations of robotic surgery. Versius fits into virtually any operating room set–up and integrates seamlessly into existing workflows, increasing the likelihood of robotic minimal access surgery (MAS). The small, portable and modular design of Versius allows the surgeon to only use the number of arms needed for a given procedure.

Biomimicking the human arm, Versius gives surgeons the choice of optimised port placement alongside the dexterity and accuracy of small fully–wristed instruments. With 3D HD vision, easy–to adopt instrument control and a choice of ergonomic working positions, the open surgeon console has the potential to reduce stress and fatigue and allows for clear communication with the surgical team. By thinking laparoscopically and operating robotically with Versius, patients, surgeons and healthcare professionals can all benefit from the value that robotic MAS brings.

But it's more than just a robot. Versius captures meaningful data with its wider digital ecosystem to support a surgeon's continuous learning. Through the Versius Connect app, Versius Trainer and CMR clinical registry, Versius unleashes a wealth of insights to ultimately improve surgical care.

About CMR Surgical Limited

CMR Surgical (CMR) is a global medical devices company dedicated to transforming surgery with Versius , a next–generation surgical robot.

Headquartered in Cambridge, United Kingdom, CMR is committed to working with surgeons, surgical teams and hospital partners, to provide an optimal tool to make robotic minimal access surgery universally accessible and affordable. With Versius, we are on a mission to redefine the surgical robotics market with practical, innovative technology and data that can improve surgical care.

Founded in 2014, CMR Surgical is private limited company backed by an international shareholder base.

GLOBENEWSWIRE (Distribution ID 1000584601)